Connecting you to content on EBSCOhost

Works by Kagiampakis, Ioannis

Results: 6

1

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331

By:

Dimopoulos, Meletios A.;
Migkou, Magdalini;
Bhutani, Manisha;
Ailawadhi, Sikander;
Kalff, Anna;
Walcott, Farzana L.;
Pore, Nabendu;
Brown, Miranda;
Wang, Fujun;
Cheng, Lily I.;
Kagiampakis, Ioannis;
Williams, Marna;
Kinneer, Krista;
Wu, Yuling;
Jiang, Yu;
Kubiak, Robert J.;
Zonder, Jeffrey A.;
Larsen, Jeremy;
Sirdesai, Shreerang;
Yee, Andrew J.

Publication type:

Article

2

Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.

Published in:

International Journal of Oncology, 2017, v. 50, n. 6, p. 2011, doi. 10.3892/ijo.2017.3979

By:

YUAN LIU;
MURRAY-STEWART, TRACY;
CASERO Jr, ROBERT A.;
KAGIAMPAKIS, IOANNIS;
LIHUA JIN;
JIAWEN ZHANG;
HUIHUI WANG;
QI CHE;
HUAN TONG;
JIEQI KE;
FEIZHOU JIANG;
FANGYUAN WANG;
XIAOPING WAN

Publication type:

Article

3

Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57181-2

By:

Arango-Argoty, Gustavo;
Kipkogei, Elly;
Stewart, Ross;
Sun, Gerald J.;
Patra, Arijit;
Kagiampakis, Ioannis;
Jacob, Etai

Publication type:

Article

4

Detecting protein dissimilarities in multiple alignments using Bayesian variable selection.

Published in:

Bioinformatics, 2007, v. 23, n. 2, p. 245

By:

Jerry Tsai;
Ioannis Kagiampakis;
Patricia LiWang;
Marina Vannucci

Publication type:

Article

5

Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES.

Published in:

Proteins, 2010, v. 78, n. 2, p. 295, doi. 10.1002/prot.22542

By:

Jin, Hongjun;
Kagiampakis, Ioannis;
Li, Pingwei;
LiWang, Patricia J.

Publication type:

Article

6

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.

Published in:

Targeted Oncology, 2024, v. 19, n. 3, p. 321, doi. 10.1007/s11523-024-01054-z

By:

Maris, Michael;
Salles, Gilles;
Kim, Won Seog;
Kim, Tae Min;
Lyons, Roger M.;
Arellano, Martha;
Karmali, Reem;
Schiller, Gary;
Cull, Elizabeth;
Abboud, Camille N.;
Batlevi, Connie;
Kagiampakis, Ioannis;
Rebelatto, Marlon C.;
Lee, Young;
Kirby, Lyndon C.;
Wang, Fujun;
Bothos, John;
Townsley, Danielle M.;
Fathi, Amir T.;
Ribrag, Vincent

Publication type:

Article